Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 6/20 | 0.54 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.54 |
| ▸ | PGR | P06401 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.54 |
| ▸ | HTR2B | P41595 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 8/20 | 0.52 |
| ▸ | SERPINA6 | P08185 | 5/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.52 |
| ▸ | SNCA | P37840 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Spriolactone SCHEMBL8260326 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL30112125 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL18218188 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL10786113 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL20459223 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL14285054 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| Spriolactone SCHEMBL8259555 | 0.85 | SHBG (0.67) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL14308729 | 0.84 | HIF1A (0.54) | SHBGNR3C1PGRLMNASERPINA6 | |
| SCHEMBL18220867 | 0.79 | SHBG (0.54) | SHBGNR3C1PGRALDH1A1ADRA1A | |
| SCHEMBL10939751 | 0.79 | SHBG (0.56) | SHBGNR3C1PGRALDH1A1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10286000-B2 | Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2019-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10286000-B2 | Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer | RXRG, RXRA, RXRB | SHBG 847/4885NR3C1 287/4885PGR 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.